H.R. 3200/Division B/Title I/Subtitle B/Part 3

{{SECTION|SEC. 1141.|SEC. 1141}}. RENTAL AND PURCHASE OF POWER-DRIVEN WHEELCHAIRS.

 * (a) In General.—
 * Section 1834(a)(7)(A)(iii) of the Social Security Act (42 U.S.C. 1395m(a)(7)(A)(iii)) is amended—
 * (1) in the heading, by inserting ``certain complex rehabilitative´´ after ``option for´´; and


 * (2) by striking ``power-driven wheelchair´´ and inserting ``complex rehabilitative power-driven wheelchair recognized by the Secretary as classified within group 3 or higher´´.


 * (b) Effective Date.—
 * The amendments made by subsection (a) shall take effect on January 1, 2011, and shall apply to power-driven wheelchairs furnished on or after such date. Such amendments shall not apply to contracts entered into under section 1847 of the Social Security Act (42 U.S.C. 1395w–3) pursuant to a bid submitted under such section before October 1, 2010, under subsection (a)(1)(B)(i)(I) of such section.

{{SECTION|SEC. 1142.|SEC. 1142}}. EXTENSION OF PAYMENT RULE FOR BRACHYTHERAPY.

 * Section 1833(t)(16)(C) of the Social Security Act (42 U.S.C. 1395l(t)(16)(C)), as amended by section 142 of the Medicare Improvements for Patients and Providers Act of 2008 (Public Law 110-275), is amended by striking, the first place it appears, ``January 1, 2010´´ and inserting ``January 1, 2012´´.

{{SECTION|SEC. 1143.|SEC. 1143}}. HOME INFUSION THERAPY REPORT TO CONGRESS.

 * Not later than 12 months after the date of enactment of this Act, the Medicare Payment Advisory Commission shall submit to Congress a report on the following:
 * (1) The scope of coverage for home infusion therapy in the fee-for-service Medicare program under title XVIII of the Social Security Act, Medicare Advantage under part C of such title, the veteran’s health care program under chapter 17 of title 38, United States Code, and among private payers, including an analysis of the scope of services provided by home infusion therapy providers to their patients in such programs.


 * (2) The benefits and costs of providing such coverage under the Medicare program, including a calculation of the potential savings achieved through avoided or shortened hospital and nursing home stays as a result of Medicare coverage of home infusion therapy.


 * (3) An assessment of sources of data on the costs of home infusion therapy that might be used to construct payment mechanisms in the Medicare program.


 * (4) Recommendations, if any, on the structure of a payment system under the Medicare program for home infusion therapy, including an analysis of the payment methodologies used under Medicare Advantage plans and private health plans for the provision of home infusion therapy and their applicability to the Medicare program.

{{SECTION|SEC. 1144.|SEC. 1144}}. REQUIRE AMBULATORY SURGICAL CENTERS (ASCS) TO SUBMIT COST DATA AND OTHER DATA.

 * (a) Cost Reporting.—
 * (1) In General.—
 * Section 1833(i) of the Social Security Act (42 U.S.C. 1395l(i)) is amended by adding at the end the following new paragraph:


 * ``(8) The Secretary shall require, as a condition of the agreement described in section 1832(a)(2)(F)(i), the submission of such cost report as the Secretary may specify, taking into account the requirements for such reports under section 1815 in the case of a hospital.´´.


 * (2) Development of Cost Report.—
 * Not later than 3 years after the date of the enactment of this Act, the Secretary of Health and Human Services shall develop a cost report form for use under section 1833(i)(8) of the Social Security Act, as added by paragraph (1).


 * (3) Audit Requirement.—
 * The Secretary shall provide for periodic auditing of cost reports submitted under section 1833(i)(8) of the Social Security Act, as added by paragraph (1).


 * (4) Effective Date.—
 * The amendment made by paragraph (1) shall apply to agreements applicable to cost reporting periods beginning 18 months after the date the Secretary develops the cost report form under paragraph (2).


 * (b) Additional Data On Quality.—
 * (1) In General.—
 * Section 1833(i)(7) of such Act (42 U.S.C. 1395l(i)(7)) is amended—
 * (A) in subparagraph (B), by inserting ``subject to subparagraph (C),´´ after ``may otherwise provide,´´; and


 * (B) by adding at the end the following new subparagraph:


 * ``(C) Under subparagraph (B) the Secretary shall require the reporting of such additional data relating to quality of services furnished in an ambulatory surgical facility, including data on health care associated infections, as the Secretary may specify.´´.


 * (2) Effective Date.—
 * The amendment made by paragraph (1) shall to reporting for years beginning with 2012.

{{SECTION|SEC. 1145.|SEC. 1145}}. TREATMENT OF CERTAIN CANCER HOSPITALS.

 * Section 1833(t) of the Social Security Act (42 U.S.C. 1395l(t)) is amended by adding at the end the following new paragraph:


 * ``(18) Authorization of adjustment for cancer hospitals.—
 * ``(A) Study.—The Secretary shall conduct a study to determine if, under the system under this subsection, costs incurred by hospitals described in section 1886(d)(1)(B)(v) with respect to ambulatory payment classification groups exceed those costs incurred by other hospitals furnishing services under this subsection (as determined appropriate by the Secretary).


 * ``(B) Authorization of adjustment.—Insofar as the Secretary determines under subparagraph (A) that costs incurred by hospitals described in section 1886(d)(1)(B)(v) exceed those costs incurred by other hospitals furnishing services under this subsection, the Secretary shall provide for an appropriate adjustment under paragraph (2)(E) to reflect those higher costs effective for services furnished on or after January 1, 2011.´´.

{{SECTION|SEC. 1146.|SEC. 1146}}. MEDICARE IMPROVEMENT FUND.

 * Section 1898(b)(1)(A) of the Social Security Act (42 U.S.C. 1395iii(b)(1)(A)) is amended to read as follows:


 * ``(A) the period beginning with fiscal year 2011 and ending with fiscal year 2019, $8,000,000,000; and´´.

{{SECTION|SEC. 1147.|SEC. 1147}}. PAYMENT FOR IMAGING SERVICES.

 * (a) Adjustment in Practice Expense to Reflect Higher Presumed Utilization.—
 * Section 1848 of the Social Security Act (42 U.S.C. 1395w) is amended—
 * (1) in subsection (b)(4)—
 * (A) in subparagraph (B), by striking ``subparagraph (A)´´ and inserting ``this paragraph´´; and


 * (B) by adding at the end the following new subparagraph:


 * ``(C) Adjustment in practice expense to reflect higher presumed utilization.—In computing the number of practice expense relative value units under subsection (c)(2)(C)(ii) with respect to advanced diagnostic imaging services (as defined in section 1834(e)(1)(B)), the Secretary shall adjust such number of units so it reflects a 75 percent (rather than 50 percent) presumed rate of utilization of imaging equipment.´´; and


 * (2) in subsection (c)(2)(B)(v)(II), by inserting ``and other provisions´´ after ``OPD payment cap´´.


 * (b) Adjustment in Technical Component ``Discount´´ on Single-Session Imaging to Consecutive Body Parts.—
 * Section 1848(b)(4) of such Act is further amended by adding at the end the following new subparagraph:


 * ``(D) Adjustment in technical component discount on single-session imaging involving consecutive body parts.—The Secretary shall increase the reduction in expenditures attributable to the multiple procedure payment reduction applicable to the technical component for imaging under the final rule published by the Secretary in the Federal Register on November 21, 2005 (part 405 of title 42, Code of Federal Regulations) from 25 percent to 50 percent.´´.


 * (c) Effective Date.—
 * Except as otherwise provided, this section, and the amendments made by this section, shall apply to services furnished on or after January 1, 2011.

{{SECTION|SEC. 1148.|SEC. 1148}}. DURABLE MEDICAL EQUIPMENT PROGRAM IMPROVEMENTS.

 * (a) Waiver of Surety Bond Requirement.—
 * Section 1834(a)(16) of the Social Security Act (42 U.S.C. 1395m(a)(16)) is amended by adding at the end the following: ``The requirement for a surety bond described in subparagraph (B) shall not apply in the case of a pharmacy (i) that has been enrolled under section 1866(j) as a supplier of durable medical equipment, prosthetics, orthotics, and supplies and has been issued (which may include renewal of) a provider number (as described in the first sentence of this paragraph) for at least 5 years, and (ii) for which a final adverse action (as defined in section 424.57(a) of title 42, Code of Federal Regulations) has never been imposed.´´.


 * (b) Ensuring Supply of Oxygen Equipment.—
 * (1) In General.—
 * Section 1834(a)(5)(F) of the Social Security Act (42 U.S.C. 1395m(a)(5)(F)) is amended—
 * (A) in clause (ii), by striking ``After the´´ and inserting ``Except as provided in clause (iii), after the´´; and


 * (B) by adding at the end the following new clause:


 * ``(iii) Continuation of supply.—In the case of a supplier furnishing such equipment to an individual under this subsection as of the 27th month of the 36 months described in clause (i), the supplier furnishing such equipment as of such month shall continue to furnish such equipment to such individual (either directly or though arrangements with other suppliers of such equipment) during any subsequent period of medical need for the remainder of the reasonable useful lifetime of the equipment, as determined by the Secretary, regardless of the location of the individual, unless another supplier has accepted responsibility for continuing to furnish such equipment during the remainder of such period.´´.


 * (2) Effective Date.—
 * The amendments made by paragraph (1) shall take effect as of the date of the enactment of this Act and shall apply to the furnishing of equipment to individuals for whom the 27th month of a continuous period of use of oxygen equipment described in section 1834(a)(5)(F) of the Social Security Act occurs on or after July 1, 2010.


 * (c) Treatment of Current Accreditation Applications.—
 * Section 1834(a)(20)(F) of such Act (42 U.S.C. 1395m(a)(20)(F)) is amended—
 * (1) in clause (i)—
 * (A) by striking ``clause (ii)´´ and inserting ``clauses (ii) and (iii)´´; and


 * (B) by striking ``and´´ at the end;


 * (2) by striking the period at the end of clause (ii)(II) and by inserting ``; and´´; and


 * (3) by adding at the end the following:


 * ``(iii) the requirement for accreditation described in clause (i) shall not apply for purposes of supplying diabetic testing supplies, canes, and crutches in the case of a pharmacy that is enrolled under section 1866(j) as a supplier of durable medical equipment, prosthetics, orthotics, and supplies.


 * ``Any supplier that has submitted an application for accreditation before August 1, 2009, shall be deemed as meeting applicable standards and accreditation requirement under this subparagraph until such time as the independent accreditation organization takes action on the supplier’s application.´´.


 * (d) Restoring 36-Month Oxygen Rental Period in Case of Supplier Bankruptcy for Certain Individuals.—
 * Section 1834(a)(5)(F) of such Act (42 U.S.C. 1395m(a)(5)(F)) is amended by adding at the end the following new clause:


 * ``(iii) Exception for bankruptcy.—If a supplier of oxygen to an individual is declared bankrupt and its assets are liquidated and at the time of such declaration and liquidation more than 24 months of rental payments have been made, the individual may begin under this subparagraph a new 36-month rental period with another supplier of oxygen.´´.

{{SECTION|SEC. 1149.|SEC. 1149}}. MEDPAC STUDY AND REPORT ON BONE MASS MMEASUREMENT.

 * (a) In General.—
 * The Medicare Payment Advisory Commission shall conduct a study regarding bone mass measurement, including computed tomography, duel-energy x-ray absorptriometry, and vertebral fracture assessment. The study shall focus on the following:
 * (1) An assessment of the adequacy of Medicare payment rates for such services, taking into account costs of acquiring the necessary equipment, professional work time, and practice expense costs.


 * (2) The impact of Medicare payment changes since 2006 on beneficiary access to bone mass measurement benefits in general and in rural and minority communities specifically.


 * (3) A review of the clinically appropriate and recommended use among Medicare beneficiaries and how usage rates among such beneficiaries compares to such recommendations.


 * (4) In conjunction with the findings under (3), recommendations, if necessary, regarding methods for reaching appropriate use of bone mass measurement studies among Medicare beneficiaries.


 * (b) Report.—
 * The Commission shall submit a report to the Congress, not later than 9 months after the date of the enactment of this Act, containing a description of the results of the study conducted under subsection (a) and the conclusions and recommendations, if any, regarding each of the issues described in paragraphs (1), (2), (3), and (4) of such subsection.